Restaurant Brands (QSR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Does BHP (BHP) have what it takes to be a top stock pick for momentum investors? Let's find out.

Quest Diagnostics (DGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Casey's (CASY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Cincinnati Financial (CINF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

SBA Communications (SBAC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Graphic Packaging Holding Company (“Graphic Packaging” or the “Company”) (NYSE: GPK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Ahafo North is starting commercial production, adding around 5% low-cost gold volume versus Newmont's current run-rate and supporting margin expansion and free cash flow growth. Ongoing SG&A and project cost reductions from workforce restructuring and organizational simplification should further improve NEMt's margins and cash flow conversion. Majority control of Nevada Gold Mines could unlock additional operational cost efficiencies on an already key 19.4% gold production and sales contributor for NEM.

NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fermi Inc. (“Fermi” or the “Company”) (NASDAQ: FRMI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

FTNT is pushing Unified SASE as a growth driver for 2026, fueled by fast FortiSASE adoption, flexible deployments and rising enterprise billings.

MTZ rides on robust public spending, witnessing backlog growth and accretive acquisitions, lifting shares despite project and weather delays.

NFLX's expansive 2026 lineup of films and hit series sets the stage for stronger engagement, rising subs and expanding advertising momentum.

Currently priced at approximately $80.53 per share, Haemonetics (NYSE: HAE) is trading roughly 7.6% below its 52-week high.

NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA (“ADC Therapeutics” or the “Company”) (NYSE: ADCT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Cherry Hill Mortgage Investment Corporation delivered solid returns in 2025, in line with mREIT peers focused on residential mortgages. The outlook for 2026 is also bright, with the company yet to see the full impact of recent Fed rate cuts on funding costs. CHMI is also interesting for third parties amid a pick-up in M&A activity and a 19% book value discount, although we have no indication of a deal in the making.

NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of SNDL Inc. (“SNDL” or the “Company”) (NASDAQ: SNDL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Air Products and Chemicals, Inc. (“Air Products” or the “Company”) (NYSE: APD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Aerovironment, Inc. (“Aerovironment” or the “Company”) (NASDAQ: AVAV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

As investors look ahead to 2026, markets are largely pricing continuity, with equity valuations assuming earnings growth remains intact, credit markets expecting refinancing to stay orderly, and policymakers continuing to project stability. David Rosenberg says that confidence rests on a narrow foundation.